Navigation Links
InterMune to Present at Bank of America Health Care Conference
Date:5/9/2008

BRISBANE, Calif., May 9 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that Dan Welch, President and Chief Executive Officer of InterMune, will present at the Bank of America 2008 Health Care Conference in Las Vegas on May 14, 2008 at 9:20 a.m. PDT (12:20 p.m EDT).

To access a live audio webcast of the presentation, investors and other interested parties may log on to the investor relations page of InterMune's corporate website at http://www.intermune.com. The company recommends logging on to the site 15 minutes prior to the start of the presentation in order to register or download any necessary software.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a research and development portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes the Phase 3 program, CAPACITY, which is evaluating pirfenidone for the treatment of patients with IPF and a research program focused on small molecules for pulmonary disease. The hepatology portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as R7227 at Roche) in Phase 1b, a second-generation HCV protease inhibitor research program, and a research program evaluating a new target in hepatology. For additional information about InterMune and its R&D pipeline, please visit http://www.intermune.com.


'/>"/>
SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. Evotec Expands Collaboration With InterMune
8. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
9. InterMune to Present at Deutsche Bank Health Care Conference
10. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
11. Avicena Group to Present at Noble Financial Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... CHICAGO, Nov. 30 Dr. Jessica Torr...ashington University Medical Center in Washington,...ast-Specific Gamma Imaging (BSGI) in clinical prac...sis of breast cancer today at the annual meeting o.... ,, "The purpose of the exhibit was to demonst...
(Date:11/30/2009)... NOVATO, Calif., Nov. 30 ...ounced today that the Food and Drug Administration...-diaminopyridine (3,4-DAP), amifampridine phosphat...yasthenic Syndrome (LEMS). 3,4-DAP has previously...o, in October 2009, the Committee for Medicinal Pr...
(Date:11/30/2009)..., BOSTON and COPENHAGEN, Nov. 30 ...ed today that the Harvard Medical School ICCB-Long...ed as a MicroRNA Screening Center of Excellence. ...chool, and associated hospitals and institutions, ...d RNAi libraries. ,, MicroRNAs are a novel clas...
(Date:11/30/2009)... , AMSTERDAM, November...s,leading publisher of scientific, medical and tec...jor re-launch of Embase, its comprehensive biomedi...ecords from more than 7,000,active, peer reviewed ...role in the advancement of new biomedical,and phar...
Breaking Biology Technology:Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3
...uals with cancer would find a noninvasive method t...seful, because low levels of oxygen in a tumor hav...o this and to image the surrounding organs and tis...to image tumors in mice by Murali Krishna and coll...esda. The importance of this technical advance for...
...om Hefei and Dutch researchers in Amsterdam have c... of new elegant methodology in Depression research... donated to the Netherlands Brain Bank for researc...part of the brain, the hypothalamus, that is known...f symptoms of depression. This region is 6 mm3 lar...
... the biggest-selling,biologics developed during th...man growth hormone (hGH) and insulin, have lost pa...y, and they represent a market,of $40 billion. Thi..., if,regulatory hurdles can be overcome, according...ics: the World Market for Biosimilars., Worldwide...
Other Biology Technology:Huge Potential in Biosimilars if Generic Providers Overcome Regulatory Hurdles 2
(Date:12/1/2009)...AND, Wash. -- Time-lapsed video of individual brea...in the life of a cell: a protein that cycles betwe... give researchers a more complete view of the inte...w, events that go awry in cancer and are targets o...lps cells respond to growth factors, travels back ...
(Date:11/30/2009)...entific organisation is needed to monitor the comm...at Copenhagen to cut their deforestation rates, ac... Existing government agencies and research groups...satellite images of the Earth,s surface collected ...a paper published by Dr Alan Grainger in the Proc...
(Date:11/30/2009)... scientists from The Forsyth Institute, the Univer... Wadsworth Center, have used state-of-the-art tech...Treponema pallidum, the bacterium which causes syp...f the bacteria can now be shown in three dimension...gen and reveals previously unknown features, which...
Breaking Biology News(10 mins):ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 4World forest observatory needed to monitor vital role of forests in climate deal 2Scientists gain new understanding of disease-causing bacteria 2Sigma Aldrich Enters Distribution Agreement With Stemgent Inc to Offer Lentivirus Based Gene Delivery Products for Regenerative Medicine and Stem Ce 6123 1Sigma Aldrich Enters Distribution Agreement With Stemgent Inc to Offer Lentivirus Based Gene Delivery Products for Regenerative Medicine and Stem Ce 6123 2Sigma Aldrich Enters Distribution Agreement With Stemgent Inc to Offer Lentivirus Based Gene Delivery Products for Regenerative Medicine and Stem Ce 6123 3Neuroimaging provides insights into new treatment options for Alzheimers disease 61064 1Climate studies to benefit from 12 years of satellite aerosol data 61062 1Climate studies to benefit from 12 years of satellite aerosol data 61062 2
...able in French . , OTTAWA The Government of C...of chemicals that can be used to make explosives. ...urces, and the Honourable Stockwell Day, Minister ...ions for these chemicals, known as explosives prec...ct. , Following extensive public consultation, the...
... American,Association of Airport Executives Presi... the Registered Traveler (RT) program with the ope...l Airport and Ronald Reagan,Washington National Ai... program to key airports in,the nation,s capital w...cing the efficiency and effectiveness of screening...
...8) — Robots are fluent in their native language of...es and imprecise nature of human language. While s... their quest to create a robot that responds to sp...orward method of communication may help robots fin...chers led by Charlie Kemp, director of the Center ...
Other Biology News:New regulations tighten controls on restricted chemicals 2AAAE Applauds Expansion of Registered Traveler Program to Nation's Capital 2AAAE Applauds Expansion of Registered Traveler Program to Nation's Capital 3Robot fetches objects with just a point and a click 2Robot fetches objects with just a point and a click 3Robot fetches objects with just a point and a click 4
Anti-IRS 2, phospho (Ser731) Polyclonal Antibody, Unconjugated from BioSource International (Invitrogen)
... for non-denaturing polyacrylamide and agarose gel... solution contains a bromophenol blue tracking dye...loading. EDTA has been included to inhibit nucleas...added to help dissociate DNA-protein complexes whi...
Gel Loading Solution (Type I) from Sigma-Aldrich
Mouse Anti-Human QPRT Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: